50% of dementia sufferers are undiagnosed and many are misdiagnosed
By 2050, 152 million people around the world will have Dementia
By 2050, 152 million people around the world will have Dementia
More than 200 experimental drugs have failed in clinical trials.
50% of dementia sufferers are undiagnosed and many are misdiagnosed
By 2050, 152 million people around the world will have Dementia
Dementia - A Global Healthcare Crisis
Oxford Brain Diagnostics' breakthrough technology aims to change the way Dementia is assessed.
Our technology Cortical Disarray Measurement seeks to bring hope to patients, clinicians and pharmaceutical companies by offering greater certainty in Alzheimer's disease diagnosis at the earliest opportunity.
We are committed to providing early diagnosis, disease prediction and progression tracking as clinical services. Our innovative technology strives to deliver products globally to patients.